Gene Transfer of Antisense B7.1 Attenuates Acute Rejection Against Liver Allografts in Rats

REFERENCES

• Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol. 2002;20:29–53.
   PubMed Web of Science ®Google Scholar
• Frauwirth KA, Thompson CB. Activation and inhibition of lymphocytes by costimulation. J Clin Invest. 2002;109:295–299.
   PubMed Web of Science ®Google Scholar
• Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med. 1998;338:1813–1821.
   PubMed Web of Science ®Google Scholar
• Satoh S, Suzuki A, Asari Y, Glomerular endothelium exhibits enhanced expression of costimulatory adhesion molecules, CD80 and CD86, by warm ischemia/reperfusion injury in rats. Lab Invest. 2002;82:1209–1217.
   Google Scholar
• Kojima N, Sato M, Suzuki A, Enhanced expression of B7-1, B7-2, and intercellular adhesion molecule 1 in sinusoidal endothelial cells by warm ischemia/reperfusion injury in rat liver. Hepatology. 2001;34:751–757.
   Google Scholar
• Rademacher J, Cansolino L, Lillo E, Blockade of B7:CD28 costimulatory pathway reduces the vascular damage in an experimental model of chronic rejection. [Italian] Minerva Chirurgica. 2005;60:487–496.
   Google Scholar
• Pearson TC, Alexander DZ, Winn KJ, Transplantation tolerance induced by CTLA4-Ig. Transplantation. 1994;57:1701–1706.
   PubMed Web of Science ®Google Scholar
• Larsen CP, Elwood ET, Alexander DZ, Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 1996;381:434–438.
   PubMed Web of Science ®Google Scholar
• Kirk AD, Tadaki DK, Celniker A, Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. Transplantation. 2001;72:377–484.
   PubMed Web of Science ®Google Scholar
• Li Y, Li XC, Zheng XX, Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med. 1999;5:1298–1302.
   PubMed Web of Science ®Google Scholar
• Olthoff KM, Judge TA, Gelman AE, Adenovirus mediated gene transfer into cold-preserved liver allografts: survival pattern and unresponsiveness following transduction with CTLA4Ig. Nat Med. 1998;4:194–200.
   PubMed Web of Science ®Google Scholar
• Yanagida N, Nomura M, Yamashita K, Tolerance induction by a single donor pretreatment with the adenovirus vector encoding CTLA4Ig gene in rat orthotopic liver transplantation. Transplant Proc. 2001;33:573–574.
   Google Scholar
• Zhu JY, Liu YN, Wang D, Transfection of CD40Ig into liver prevents acute rejection in rat liver. Transplantation. 2005;37:4571–4574.
   Google Scholar
• Liu C, Pan S, Jiang H, Gene transfer of antisense B7.1 protects splenic allografts from acute rejection in rats. Transplant Proc. 2007;39:3391–3395.
   Google Scholar
• Jiang H, Liu C, Xu J, Gene transfer of interleukin-4 delays acute rejection of splenic allografts in rats. Transplant Proc. 2004;36:1600–1603.
   Google Scholar
• Chimalakonda AP, Montgomery DL, Weidanz JA, Attenuation of acute rejection in a rat liver transplantation model by a liver-targeted dextran prodrug of methylprednisolone. Transplantation. 2006;81:678–685.
   Google Scholar
• Tsuchimoto S, Kusumoto K, Nakajima Y, Orthotopic liver transplantation in the rat. A simplified technique using the cuff method for suprahepatic vena cava anastomosis. Transplantation. 1988;45:1153–1155.
   PubMedGoogle Scholar
• Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplantation in the rats. Surgery. 1983;93:64–69.
   PubMed Web of Science ®Google Scholar
• Demetrius AJ, Batts KP, Dhillon AP, Banff schema for grading liver allograft rejection: an international consensus document. Hepatology. 1997;25:658–663.
   PubMed Web of Science ®Google Scholar
• Ma L, Luo L, Qiao H, Vasostatin synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas. J Hepatol. 2006;46:98–106.
   PubMed Web of Science ®Google Scholar
• Versluis DJ, Ten Kate FJW, Wenting GJ, Mononuclear cells infiltrating kidney allografts in the absence of rejection. Transplant Int. 1988;1:205–208.
   Google Scholar
• Yamashita K, Masunaga T, Yanagida N, Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies. Transplantation. 2003;76:1089–1096.
   Google Scholar
• Bartlett AS, McCall JL, Ameratunga R, Analysis of intragraft gene and protein expression of the costimulatory molecules, CD80, CD86 and CD154, in orthotopic liver transplant recipients. Am J Transplant. 2003;3:1363–1368.
   Google Scholar
• Leifeld L, Trautwein C, Dumoulin FL, Enhanced expression of CD80 (B7–1), CD86 (B7–2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. Am J Pathol. 1999;154:1711–1720.
   PubMed Web of Science ®Google Scholar
• Lohse AW, Knolle PA, Bilo K, Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology. 1996;110:1175–1181.
   PubMed Web of Science ®Google Scholar
• Knolle PA, Germann T, Treichel U, Endotoxin down-regulates T cell activation by antigen presenting liver sinusoidal endothelial cells. J Immunol. 1999;162:1401–1407.
   PubMed Web of Science ®Google Scholar
• De Greef KE, Ysebaert DK, Dauwe S, Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int. 2001;60:1415–1427.
   Google Scholar
• Marelli-Berg FM, Frasca L, Weng L, Antigen recognition influences transendothelial migration of CD4+ T cells. J Immunol. 1999;162:696–703.
   Google Scholar
• Krieger NR, Yin DP, Fathman CG. CD4+ but not CD8+ Cells are essential for allorejection. J Exp Med. 1996;184:2013–2018.
   PubMed Web of Science ®Google Scholar
• Ibrahim S, Dawson DV, Killenberg PG, The pattern and phenotype of T-cell infiltration associated with human liver allograft rejection. Human Pathol. 1993;24:1365–1370.
   Google Scholar
• Kubota N, Sugitani M, Takano S, Correlation between acute rejection severity and CD8-positive T cells in living related liver transplantation. Transpl Immunol. 2006;16:60–64.
   Google Scholar
• Giles R. Antisense oligonucleotide technology: from EST to therapeutics. Curr Opin Mol Ther. 2000;2:238–252.
   Google Scholar
• Machen J, Harnaha J, Lakomy R, Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells. J Immunol. 2004;173:4331–4341.
   PubMed Web of Science ®Google Scholar
• Zabner J, Ramsey BW, Meeker DP. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest. 1996;97:1504–1511.
   PubMed Web of Science ®Google Scholar
• Fisher KJ, Choi H, Burda J. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology. 1996;217:11–22.
   PubMed Web of Science ®Google Scholar
• Dalesandro J, Akimoto H, Gorman CM, Gene Therapy for donor hearts: ex vivo liposome-mediated transfection. J Thorac Cardiovasc Surg. 1996;111:416–421.
   PubMed Web of Science ®Google Scholar